What is Zacks Research’s Estimate for STERIS Q3 Earnings?

STERIS plc (NYSE:STE) – Equities researchers at Zacks Research upped their Q3 2025 earnings estimates for STERIS in a research report issued on Tuesday, December 24th. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings per share of $2.30 for the quarter, up from their prior estimate of $2.29. The consensus estimate for STERIS’s current full-year earnings is $9.10 per share. Zacks Research also issued estimates for STERIS’s Q4 2025 earnings at $2.60 EPS, FY2025 earnings at $9.07 EPS, Q1 2026 earnings at $2.25 EPS, Q3 2026 earnings at $2.50 EPS, FY2026 earnings at $9.92 EPS, Q1 2027 earnings at $2.47 EPS and FY2027 earnings at $10.25 EPS.

A number of other equities analysts have also weighed in on STE. Stephens reissued an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research report on Thursday, November 7th. KeyCorp increased their price objective on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a research report on Tuesday, September 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. StockNews.com cut STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Finally, Piper Sandler raised STERIS from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $262.50.

STERIS Stock Up 0.0 %

STE stock opened at $208.72 on Friday. The stock has a market capitalization of $20.60 billion, a P/E ratio of 47.65 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55. STERIS has a 1-year low of $197.82 and a 1-year high of $248.24. The business has a fifty day moving average price of $217.81 and a 200-day moving average price of $226.23.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.12 by $0.02. The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.03 earnings per share.

Institutional Investors Weigh In On STERIS

A number of institutional investors and hedge funds have recently added to or reduced their stakes in STE. Ashton Thomas Securities LLC bought a new stake in shares of STERIS during the third quarter valued at approximately $25,000. Central Pacific Bank Trust Division purchased a new stake in shares of STERIS in the 3rd quarter worth $28,000. Brown Brothers Harriman & Co. increased its stake in shares of STERIS by 154.7% during the second quarter. Brown Brothers Harriman & Co. now owns 191 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 116 shares during the period. Isthmus Partners LLC purchased a new stake in STERIS in the second quarter worth about $44,000. Finally, Mascoma Wealth Management LLC bought a new position in STERIS during the 2nd quarter worth about $61,000. Institutional investors own 94.69% of the company’s stock.

Insider Transactions at STERIS

In related news, SVP Cary L. Majors sold 1,682 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the completion of the sale, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. This trade represents a 12.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.14% of the company’s stock.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.09%. The ex-dividend date of this dividend was Tuesday, November 19th. STERIS’s payout ratio is 52.05%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.